Labcorp (LH) announced the appointment of Victor Bulto, a seasoned pharmaceutical executive and member of Novartis’ executive leadership team, to its Board of Directors, effective December 1, 2025. Bulto currently oversees Novartis’ (NVS) U.S. business.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH: